NanoVation Therapeutics is a pioneer in the design and creation of lipid nanoparticles (LNPs) for nucleic acid delivery. NanoVation’s LNP technologies aim to overcome the limitations of existing nucleic acid delivery approaches, including the ability to target tissues outside the liver (extrahepatic delivery).

NanoVation partners with leading pharmaceutical and biotech companies to develop genetic medicines for previously untreatable diseases. NanoVation's toolbox offers a "one-stop-shop" IP portfolio for LNP-based genetic medicine development, with comprehensive solutions spanning novel lipid designs, RNA modifications and LNP compositions.

We are building our team and looking for highly motivated individuals to deliver tomorrow's genetic medicines, today. For more information, please visit nanovationtx.com.